Zeba Niazi Singh, MBBS is an Associate Professor of Pathology at the University of Maryland School of Medicine Baltimore. Her academic and research interest is in myeloid malignancies, both acute and chronic, and specifically the progression of dysplastic, “preleukemic” marrow to overt leukemia, and therapy-related myeloid neoplasms. Her clinical and research interest is multiple myeloma and the development of secondary myeloid neoplasms occurring in the context of prior therapy for myeloma. She is interested in the genetic abnormalities and specifically in the advances in the techniques employed in evaluation of these abnormalities at the chromosome and gene level.
Dr. Singh attended The University of Chicago for her residency in Anatomic Pathology and the University of North Carolina at Chapel Hill for a fellowship in Molecular Genetic Pathology.
